Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO).
Zamboglou C, Aebersold DM, Albrecht C, Boehmer D, Ganswindt U, Schmidt-Hegemann NS, Hoecht S, Hölscher T, Koerber SA, Mueller AC, Niehoff P, Peeken JC, Pinkawa M, Polat B, Spohn SKB, Wolf F, Zips D, Wiegel T. Zamboglou C, et al. Among authors: spohn skb. Strahlenther Onkol. 2024 Aug 28. doi: 10.1007/s00066-024-02288-6. Online ahead of print. Strahlenther Onkol. 2024. PMID: 39196366
Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients.
Spohn S, Jaegle C, Fassbender TF, Sprave T, Gkika E, Nicolay NH, Bock M, Ruf J, Benndorf M, Gratzke C, Grosu AL, Zamboglou C. Spohn S, et al. Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2796-2803. doi: 10.1007/s00259-020-04827-6. Epub 2020 Apr 28. Eur J Nucl Med Mol Imaging. 2020. PMID: 32342192 Free PMC article.
Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis.
Schmidt Hegemann NS, Rogowski P, Eze C, Schäfer C, Stief C, Lang S, Spohn S, Steffens R, Li M, Gratzke C, Schultze-Seemann W, Ilhan H, Fendler WP, Bartenstein P, Ganswindt U, Buchner A, Grosu AL, Belka C, Meyer PT, Kirste S, Zamboglou C. Schmidt Hegemann NS, et al. Cancers (Basel). 2020 Nov 16;12(11):3395. doi: 10.3390/cancers12113395. Cancers (Basel). 2020. PMID: 33207785 Free PMC article.
Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis.
Stoian R, Erbes T, Zamboglou C, Scholber J, Gainey M, Sachpazidis I, Haehl E, Spohn SKB, Verma V, Krug D, Rühle A, Juhasz-Böss I, Grosu AL, Nicolay NH, Sprave T. Stoian R, et al. Among authors: spohn skb. Strahlenther Onkol. 2021 Sep;197(9):812-819. doi: 10.1007/s00066-021-01785-2. Epub 2021 Apr 30. Strahlenther Onkol. 2021. PMID: 33938966 Free PMC article.
A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa.
Schmidt-Hegemann NS, Zamboglou C, Thamm R, Eze C, Kirste S, Spohn S, Li M, Stief C, Bolenz C, Schultze-Seemann W, Bartenstein P, Prasad V, Ganswindt U, Grosu AL, Belka C, Mayer B, Wiegel T. Schmidt-Hegemann NS, et al. Front Oncol. 2021 Oct 1;11:723536. doi: 10.3389/fonc.2021.723536. eCollection 2021. Front Oncol. 2021. PMID: 34660290 Free PMC article.
PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial.
Zamboglou C, Spohn SKB, Adebahr S, Huber M, Kirste S, Sprave T, Gratzke C, Chen RC, Carl EG, Weber WA, Mix M, Benndorf M, Wiegel T, Baltas D, Jenkner C, Grosu AL. Zamboglou C, et al. Among authors: spohn skb. Cancers (Basel). 2021 Nov 18;13(22):5795. doi: 10.3390/cancers13225795. Cancers (Basel). 2021. PMID: 34830950 Free PMC article.
52 results